By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cynapsus Therapeutics 

828 Richmond Street W

Toronto  Ontario  M6J  Canada
Phone: n/a Fax: n/a



Company News
Cynapsus Therapeutics Awarded Second Grant From The Michael J. Fox Foundation For Parkinson's Research 7/8/2014 10:24:34 AM
Cynapsus Therapeutics Announces No Buccal Mucosal Irritation In FDA Registration Study Of APL-130277 For Parkinson’s Disease 5/14/2014 11:55:20 AM
Cynapsus Therapeutics Announces Positive Results Of CTH-104 Clinical Study Of APL-130277 For Parkinson's Disease 4/24/2014 10:46:06 AM
Cynapsus Therapeutics Completes $25,000,000 Short Form Prospectus Offering 4/23/2014 1:52:29 PM
Cynapsus Therapeutics Reports 2013 Financial Results And Highlights Key Developments 4/2/2014 10:51:49 AM
Cynapsus Therapeutics Announces Interim Summary Results Of Human Healthy Volunteer Single 25mg Study For APL-130277 4/2/2014 10:48:21 AM
LifeSci Advisors Initiates Coverage Of Cynapsus Therapeutics 2/10/2014 9:21:19 AM
Cynapsus Therapeutics Announces Completion Of Human Healthy Volunteer Crossover Study Results For APL-130277 1/13/2014 12:28:43 PM
Cynapsus Therapeutics Researching Ways to Help Parkinson's Patients Increase Control Over Their "Frozen" Bodies 10/8/2013 8:37:36 AM
Cynapsus Therapeutics Completes $6 Million Short Form Prospectus Offering 3/4/2013 7:00:15 AM